Configurational Analysis of ESG Performance, Innovation Intensity, and Financial Leverage: a Study on Total Factor Productivity in Chinese Pharmaceutical Manufacturing Firms

Juan Tan () and Jinyu Wei
Additional contact information
Juan Tan: Tianjin University of Technology, Xiqing District
Jinyu Wei: Tianjin University of Technology, Xiqing District

Journal of the Knowledge Economy, 2024, vol. 15, issue 3, No 139, 13803-13827

Abstract: Abstract Environmental, social, and governance (ESG) performance has emerged as a critical aspect of responsible investing, garnering global attention within the investment community. Unlike traditional financial metrics, ESG encompasses non-financial factors such as corporate sustainability, governance practices, and ethical considerations. This paper delves into the interplay between ESG pillars, innovation intensity, financial leverage, and total factor productivity (TFP) within Chinese pharmaceutical manufacturing firms. We scrutinize the complex causal relationships among these variables by employing a hybrid methodology combining necessary condition analysis (NCA) and fuzzy set qualitative comparative analysis (fsQCA). Our findings reveal that individual ESG factors, R&D investment, and financial leverage are not singularly necessary conditions for high TFP. Instead, a balanced approach that integrates social performance, financial leverage, and innovation intensity emerges as a critical driver of TFP in this industry. The study identifies specific configurations that lead to high TFP, emphasizing the multifaceted nature of productivity determinants. Our research provides actionable insights for pharmaceutical manufacturing companies. They can enhance their enterprise value by strategically allocating resources and capabilities, considering factors like ESG performance and financial leverage. Additionally, the study underscores the importance of transparency through CSR initiatives, suggesting that publishing non-financial information can bolster corporate reputation and ultimately drive TFP. This study advances theoretical understanding and offers valuable implications for practitioners seeking to optimize productivity in the pharmaceutical manufacturing sector while adhering to sustainable and socially responsible business practices.

Keywords: ESG performance; Innovation intensity; Knowledge dynamics; Pharmaceutical manufacturing; Corporate social responsibility; Total factor productivity (search for similar items in EconPapers)
Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s13132-023-01678-y Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:jknowl:v:15:y:2024:i:3:d:10.1007_s13132-023-01678-y

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/13132

DOI: 10.1007/s13132-023-01678-y

Access Statistics for this article

Journal of the Knowledge Economy is currently edited by Elias G. Carayannis

More articles in Journal of the Knowledge Economy from Springer, Portland International Center for Management of Engineering and Technology (PICMET)
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().